Consolidated Profit and Loss Account for the year ended 31 December 2003 2003 2002 Pre exceptional Exceptional Pre exceptional Execeptional items and items and items and items and goodwill goodwill Total goodwill goodwill Total Notes m m m m m m Turnover 2 353.3 353.3 329.6 329.6 Cost of sales 101.5 101.5 94.7 94.7 Gross profit 251.8 251.8 234.9 234.9 Investment in research and development 106.1 106.1 95.7 95.7 Selling, marketing and distribution expenses 67.4 67.4 71.5 71.5 Corporate and general administration expenses excluding exceptional items and goodwill charges 31.3 31.3 26.8 26.8 Exceptional items 5 18.9 18.9 Goodwill amortisation 94.2 94.2 93.7 93.7 Administration expenses 4 31.3 113.1 144.4 26.8 93.7 120.5 Operating profit loss before other income 47.0 113.1 66.1 40.9 93.7 52.8 Other income 3 2.5 2.5 8.1 8.1 Operating profit loss 4 49.5 113.1 63.6 49.0 93.7 44.7 Losses on the termination of operations 5 14.6 14.6 Provision against fixed asset investment 5 7.0 7.0 Profit loss on ordinary activities before interest 49.5 134.7 85.2 49.0 93.7 44.7 Net interest receivable 6 2.7 2.7 1.4 1.4 Profit loss on ordinary activities before taxation 52.2 134.7 82.5 50.4 93.7 43.3 Tax on profit loss on ordinary activities 8 7.8 36.4 28.6 7.6 5.1 2.5 Profit loss on ordinary activities after taxation 24 44.4 98.3 53.9 42.8 88.6 45.8 Preference share dividend 24 0.1 0.1 0.2 0.2 Transfer to from profit and loss reserve 44.3 98.3 54.0 42.6 88.6 46.0 Basic earnings loss per share pence 9 16.0 n a 19.5 15.5 n a 16.7 Diluted earnings loss per share pence 9 16.0 n a 19.5 15.4 n a 16.7 The results presented above arise from continuing operations.
Oxford GlycoSciences OGS has been consolidated as from 14 April 2003.
Included in the operating result within the investment in research and development charge of 106.1 million is 3.9 million of costs in respect of continuing projects acquired with OGS.
No turnover has been consolidated in respect of OGS.
